H. Kolb, K. Dannehl and D. Gruneklee, “Prospective Analysis of Islet Cell Antibodies in Children with Type 1 (Insulindependent) Diabetes,” Diabetologia, Vol. 31, No. 4, 1988, pp. 189-194. doi:10.1007/BF00290583
 M. R. Batstra, M. Pina, J. Quan, et al., “Fluctuations in GAD65 Antibodies after Clinical Diagnosis of IDDM in Young Children,” Diabetes Care, Vol. 20, No. 4, 1997, pp. 642-644. doi:10.2337/diacare.20.4.642
 M. Landin-Olsson, J. P. Palmer, A. Lernmarks, L. Blom, G. Sundkvist, L. Nystrm and G. Dahlquist, “Predictive Value of Islet Cell and Insulin Autoantibodies for Type 1 (Insulin-Dependent) Diabetes Mellitus in a Population-Based Study of Newly-Diagnosed Diabetic and Matched Control Children,” Diabetologia, Vol. 35, No. 11, 1992, pp. 1068-1073. doi:10.1007/BF02221683
 E. Kawasaki and K. Eguchi, “Is Type 1 Diabetes in the Japanese Population the Same as among Caucasians?” Annals of the New York Academy of Sciences, Vol. 1037, 2004, pp. 96-103. doi:10.1196/annals.1337.014
 T. Kobayashi, S. Sawano, T. Itoh, T. Sugimoto, T. Tanaka and S. Suwa, “The Prevalence of Islet-Cell Antibodies and Complement-Fixing Islet-Cell Antibodies in Japanese Diabetics,” Endocrinologia Japonica, Vol. 28, No. 4, 1981, pp. 429-433. doi:10.1507/endocrj1954.28.429
 Y. S. Lee, W. Y. Ng, A. C. Thai, K. F. Lui and K. Y. Loke, “Prevalence of ICA and GAD Antibodies at Initial Presentation of Type 1 Diabetes Mellitus in Singapore Children,” Journal of Pediatric Endocrinology and Metabolism, Vol. 14, No. 6, 2001, pp. 767-772. doi:10.1515/JPEM.2001.14.6.767
 A. L. Todd, W. Y. Ng, K. F. Lui and A. C. Thai, “Low Prevalence of Autoimmune Diabetes Markers in a Mixed Ethnic Population of Singaporean Diabetics,” Internal Medicine Journal, Vol. 34, No. 1-2, 2004, pp. 24-30. doi:10.1111/j.1444-0903.2004.00482.x
 D. G. McLarty, I. Athaide, G. F. Bottazzo, A. M. Swai and K. G. Alberti, “Islet Cell Antibodies Are Not Specifically Associated with Insulindependent Diabetes in Tanzanian Africans,” Diabetes Research and Clinical Practice, Vol. 9, No. 3, 1990, pp. 219-224. doi:10.1016/0168-8227(90)90048-X
 M. A. Omar, G. Bottazzo and A. C. Asmal, “Islet Cell Antibodies and Other Autoantibodies in South African Blacks and INDIANS with Insulin Dependent Diabetes Mellitus (IDDM),” Hormone and Metabolic Research, Vol. 18, No. 2, 1986, pp. 126-128. doi:10.1055/s-2007-1012247
 W. H. Peters, F. T. Lester, K. D. Kohnert and W. Hildmann, “The Frequency of Islet Cell Surface Antibodies in Newly Diagnosed Diabetics from Ethiopia,” Experimental and Clinical Endocrinology, Vol. 87, No. 3, 1986, pp. 326-332. doi:10.1055/s-0029-1210562
 V. R. Panz, W. J. Kalk, M. Zouvanis and B. I. Joffe, “Distribution of Autoantibodies to Glutamic Acid Decarboxylase across the Spectrum of Diabetes Mellitus Seen in South Africa,” Diabetic Medicine, Vol. 17, No. 3, 2000, pp. 524-527. doi:10.1046/j.1464-5491.2000.00324.x
 M. Neufeld, N. K. Maclaren, W. J. Riley, D. Lezotte, J. V. McLaughlin, J. Silverstein and A. L. Rosenbloom, “Islet Cell and Other Organ-Specific Antibodies in U.S. Caucasians and Blacks with Insulin-Dependent Diabetes Mellitus,” Diabetes, Vol. 29, 1980, pp. 589-592. doi:10.2337/diabetes.29.8.589
 I. M. Libman, M. Pietropaolo, M. Trucco, J. S. Dorman, R. E. LaPorte and D. Becker, “Islet Cell Autoimmunity in White and Black Children and Adolescents with IDDM,” Diabetes Care, Vol. 21, No. 11, 1998, pp. 1824-1827.
 N. A. Kulaylat and H. Narchi, “A Twelve Year Study of the Incidence of Childhood Type 1 Diabetes Mellitus in the Eastern Province of Saudi Arabia,” Journal of Pediatric Endocrinology and Metabolism, Vol. 13, No. 2, 2000, pp. 135-140.
 L. H. Damanhouh, J. A. Dromey, M. R. Christie, H. A. Nasrat, M. S. M. Ardawi, R. A. Robins and I. Todd, “Autoantibodies to GAD and IA-2 in Saudi Arabian Diabetic Patients,” Diabetic Medicine, Vol. 22, No. 4, 2005, pp. 448-452. doi:10.1111/j.1464-5491.2005.01438.x
 G. Blohmé, L. Nystrom, H. J. Arnqvist, F. Lithner, B. Littorin, P. O. Olsson, B. Scherstén, L. Wibell and J. Ostman, “Male Predominance of Type 1 (Insulin-Dependent) Diabetes Mellitus in Young Adults: Results from a 5-Year Prospective Nationwide Study of the 15 - 34-Year Age Group in Sweden,” Diabetologia, Vol. 35, No. 1, 1992, pp. 56-62.
 W. A. Hagopian, G. B. Sanjeevi, I. Kockum, M. Landin-Olsson, A. E. Karlsen, G. Sundkvist, et al., “Glutamate Decarboxylase-, Insulin-, and Islet Cell-Antibodies and HLA Typing to Detect Diabetes in a General Population-Based Study of Swedish Children,” Journal of Clinical Investigation, Vol. 95, No. 4, 1995, pp. 1505-1511. doi:10.1172/JCI117822
 J. R. Bilbao, I. Rica, J. A. Vazquez, M. A. Busturia and L. Castano, “Influence of Sex and Age at Onset on Autoantibodies against Insulin, GAD65 and 1A2 in Recent Onset Type 1 Diabetic Patients,” Hormone Research, Vol. 54, 2000, pp. 181-185. doi:10.1159/000053256
 A. Williams, A. Norcross, R. Dix, K. Gillespie, E. Gale and P. Bingley, “The Prevalence of Insulin Autoantibodies at the Onset of Type 1 Diabetes Is Higher in Males than Females during Adolescence,” Diabetologia, Vol. 46, No. 10, 2003, pp. 1354-1356. doi:10.1007/s00125-003-1197-2